Apyx Medical (APYX) Proxy Filing summary

Executive summary

• The 2024 Annual Meeting is scheduled for August 8, 2024, with voting on director elections and auditor ratification.

• Proxy materials, including the 10-K, are available online, and shareholders are encouraged to vote by proxy, phone, or online.

• The record date for voting is June 13, 2024, with 34,643,926 shares outstanding.

• The Board recommends voting FOR all director nominees and FOR the ratification of RSM US LLP as auditor.

Voting matters and shareholder proposals

• Shareholders will vote on electing eight directors and ratifying RSM US LLP as the independent auditor for 2024.

• Shareholder proposals for the 2025 meeting must be submitted by February 26, 2025, for inclusion in the proxy statement.

• No cumulative voting; each share equals one vote.

Board of directors and corporate governance

• Eight directors are nominated for re-election, with seven deemed independent under NASDAQ and SEC rules.

• The Board is led by a non-executive Chairperson, with a Lead Independent Director coordinating independent director activities.

• Four standing committees: Audit, Compensation, Governance and Nominating, and Regulatory Compliance, all composed of independent directors.

• Annual Board and committee evaluations are conducted for effectiveness.

• Board diversity includes gender and ethnic representation, with recent additions focused on enhancing diversity.